Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Title Synthetic drugs : scope and trends in synthetic cannabinoids and stimulants / Terrence L. Gray and Sage F. Evans, editors.
Imprint Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012.

Series Substance abuse assessment, interventions and treatment
Drug transit and distribution, interception and control
Substance abuse assessment, interventions and treatment.
Drug transit and distribution, interception and control.
Subject Designer drugs.
Alt Name Gray, Terrence L.
Evans, Sage F.
Series Substance abuse assessment, interventions and treatment
Drug transit and distribution, interception and control
Substance abuse assessment, interventions and treatment.
Drug transit and distribution, interception and control.
Subject Designer drugs.
Alt Name Gray, Terrence L.
Evans, Sage F.
Description 1 online resource (xi, 122 pages) : illustrations.
polychrome rdacc
Bibliography Note Includes bibliographical references and index.
Contents SYNTHETIC DRUGS: SCOPE AND TRENDS IN SYNTHETIC CANNABINOIDS AND STIMULANTS; SYNTHETIC DRUGS: SCOPE AND TRENDS IN SYNTHETIC CANNABINOIDS AND STIMULANTS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: SYNTHETIC DRUGS: OVERVIEW AND ISSUES FOR CONGRESS; SUMMARY; BACKGROUND ON SYNTHETIC AND DESIGNER DRUGS; SCHEDULING OF SYNTHETIC DRUGS: CONTROLLED SUBSTANCES ACT; CURRENT TRENDS IN SELECTED SYNTHETICS; SELECTED LEGISLATION IN THE 112TH CONGRESS; ISSUES; Chapter 2: STATEMENT OF SENATOR DIANNE FEINSTEIN. HEARING ON ''DANGEROUS SYNTHETIC DRUGS""
Chapter 3: STATEMENT OF SENATOR CHARLES GRASSLEY. HEARING ON "DANGEROUS SYNTHETIC DRUGS"Chapter 4: STATEMENT OF JOSEPH RANNAZZISI, DEA DEPUTY ASSISTANT ADMINISTRATOR. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; INTRODUCTION; SITUATIONAL OVERVIEW; CURRENT EFFORTS AND CHALLENGES -- TEMPORARY SCHEDULING AND PROSECUTION UNDER THE ANALOGUE STATUTE; CONCLUSION; Chapter 5: STATEMENT OF ERICA LEARY, PROGRAM MANAGER, NORTH COASTAL PREVENTION COALITION. HEARING ON"DANGEROUS SYNTHETIC DRUGS"; THE IMPACT OF SYNTHETIC MARIJUANA IN SAN DIEGO COUNTY; ACCESS, AVAILABILITY, AND PROMOTION.
EFFORTS UNDERTAKEN TO COMBAT THE PROBLEMHOW THE COMBATING DANGEROUS DESIGNER DRUGS ACT OF 2011 WILL HELP COMMUNITIES; WHY COMMUNITY COALITIONS ARE KEYS TO SUCCESS; Chapter 6: STATEMENT OF MIKE ROZGA. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; Chapter 7: AFFIDAVIT OF ANTHONY SCALZO, MD. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; Chapter 8: SYNTHETIC CANNABINOIDS AND SYNTHETIC CATHINONES REPORTED IN NFLIS, 2009-2010; HIGHLIGHTS; INTRODUCTION; NATIONAL AND REGIONAL ESTIMATES; SYNTHETIC CANNABINOIDS AND SYNTHETICCATHINONES, BY STATE IN NFLIS, 2010; NATIONAL POISON CONTROL CENTER DATA.
APPENDIX. CHEMICAL NAMES OF SYNTHETIC CANNABINOIDS AND SYNTHETIC CATHINONESChapter 9: NIDA INFOFACTS: SPICE; HOW IS SPICE ABUSED?; EXTENT OF USE; WHAT ARE THE HEALTH EFFECTS OF SPICE ABUSE?; OTHER INFORMATION SOURCES; RESOURCES; Chapter 10: JWH-018 1-PENTYL-3-(1-NAPHTHOYL) INDOLE [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; ILLICIT USES; USER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 11: JWH-073 1-BUTYL-3-(1-NAPHTHOYL) INDOLE [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY.
ILLICIT USESUSER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 12: 3,4-METHYLENEDIOXYPYROVALERONE (MDPV); INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; USER POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 13: NIDA INFOFACTS: METHAMPHETAMINE; HOW IS METHAMPHETAMINE ABUSED?; HOW DOES METHAMPHETAMINE AFFECT THE BRAIN?; WHAT OTHER ADVERSE EFFECTS DOES METHAMPHETAMINE HAVE ON HEALTH?; WHAT TREATMENT OPTIONS EXIST?; HOW WIDESPREAD IS METHAMPHETAMINE ABUSE?; OTHER INFORMATION SOURCES; REFERENCES; Chapter 14: NIDA INFOFACTS: MDMA (ECSTASY); HOW IS MDMA ABUSED?
Note Print version record.
ISBN 9781620818268 (electronic bk.)
1620818264 (electronic bk.)
9781620818138
1620818132
OCLC # 844975955
Additional Format Print version: Synthetic drugs. Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012 9781620818138 (OCoLC)834070198


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team